hematoxylin has been researched along with Polycystic Ovary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Feng, X; Gao, Q; Hou, L; Wang, Y | 1 |
| Cao, H; Gao, Y; Huang, Z; Jin, L; Li, B; Ma, X; Mo, S; Wu, J; Zhang, K; Zhi, Y | 1 |
2 other study(ies) available for hematoxylin and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
HDAC5 inhibits ovarian angiogenesis in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
Topics: Angiogenesis Inducing Agents; Angiopoietins; Animals; Catalase; Dehydroepiandrosterone; Disease Models, Animal; Eosine Yellowish-(YS); Female; Hematoxylin; Histone Deacetylases; Humans; Malondialdehyde; Mice; Mice, Inbred C57BL; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-sis; Reactive Oxygen Species; Superoxide Dismutase | 2022 |
The efficacy and mechanism of Angelica sinensis (Oliv.) Diels root aqueous extract based on RNA sequencing and 16S rDNA sequencing in alleviating polycystic ovary syndrome.
Topics: AMP-Activated Protein Kinases; Angelica sinensis; Animals; DNA, Ribosomal; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Insulin Resistance; Insulins; Letrozole; Peroxisome Proliferator-Activated Receptors; Phosphatidylinositol 3-Kinases; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Rats; Sequence Analysis, RNA | 2023 |